Insider Transactions in Q1 2025 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2025
|
Michael Geffner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,657
-1.97%
|
$61,111
$23.59 P/Share
|
|
Jan 22
2025
|
Jay S Stout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,195
-1.54%
|
$50,485
$23.59 P/Share
|
|
Jan 15
2025
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,298
-0.35%
|
$55,152
$24.0 P/Share
|
|
Jan 15
2025
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,383
-0.16%
|
$57,192
$24.0 P/Share
|
|
Jan 15
2025
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,767
-0.45%
|
$210,408
$24.0 P/Share
|
|
Jan 13
2025
|
Roivant Sciences Ltd. |
BUY
Open market or private purchase
|
Direct |
16,845,010
+14.84%
|
$336,900,200
$20.0 P/Share
|
|
Jan 08
2025
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,105
-0.52%
|
$122,520
$24.1 P/Share
|
|
Jan 08
2025
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,105
-1.24%
|
$98,520
$24.1 P/Share
|